Litcius/Paper detail

ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety

Ursula A. Matulonis, Jørn Herrstedt, Amit M. Oza, Sven� Mahner, Andrés Redondo, Dominique Berton, J. S. Berek, Charlotte Aaquist Haslund, Frederik Marmé, Antonio González‐Martín, Stéphanie Bécourt, Anna V. Tinker, Jonathan A. Ledermann, Benedict B. Benigno, Gabriel Lindahl, Nicoletta Colombo, Izabela A. Malinowska, Wenlei Liu, Manjinder Bains, Bradley J. Monk, Mansoor R. Mirza

2025Gynecologic Oncology10 citationsDOI

Topics & Concepts

MedicineNova (rocket)OncologyOvarian cancerTerm (time)GynecologyInternal medicineCancerQuantum mechanicsAeronauticsEngineeringPhysicsPARP inhibition in cancer therapyAdvanced Breast Cancer TherapiesLung Cancer Research Studies
ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety | Litcius